Net profit of Piramal Pharma rose 51.58% to Rs 153.50 crore in the quarter ended March 2025 as against Rs 101.27 crore during the previous quarter ended March 2024. Sales rose 7.90% to Rs 2754.07 crore in the quarter ended March 2025 as against Rs 2552.36 crore during the previous quarter ended March 2024.
For the full year,net profit rose 411.39% to Rs 91.13 crore in the year ended March 2025 as against Rs 17.82 crore during the previous year ended March 2024. Sales rose 11.99% to Rs 9151.18 crore in the year ended March 2025 as against Rs 8171.16 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 2754.07 | 2552.36 | 8 | 9151.18 | 8171.16 | 12 |
| OPM % | 20.37 | 20.76 | - | 15.79 | 14.64 | - |
| PBDT | 515.56 | 454.13 | 14 | 1230.98 | 982.65 | 25 |
| PBT | 272.80 | 258.00 | 6 | 414.64 | 242.08 | 71 |
| NP | 153.50 | 101.27 | 52 | 91.13 | 17.82 | 411 |